In a week that started with a terrible attack on the Jewish community in Bondi and with ramifications nationally and globally – there is a need more than ever to lean on, strengthen and protect community. As we mourn each individual who needlessly lost their lives, it is communities which will carry their families through […]
GENEVA – The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria today unanimously approved a new response mechanism to support countries to respond to COVID-19 and mitigate the impact on programs to fight HIV, TB, malaria and systems for health, effectively doubling the amount of available funding to up to US$1 billion. The […]
06 October 2021 WHO recommendation for wider use of the RTS,S malaria vaccine is largely based on data gathered during malaria vaccine pilots which took place in Kenya, Ghana and Malawi Gavi, the Vaccine Alliance, the Global Fund to Fight AIDS, Tuberculosis and Malaria and global health agency Unitaid have together committed nearly US$ 70 […]
A REGIONAL COVID RESPONSE NEEDS MORE FROM AUSTRALIA Media Release | 23 September 2021 Pacific Friends of Global Health welcomes the news that the Australian Government has pledged an additional 40 million COVID-19 vaccines for the Indo-Pacific region. Australia has now promised a total of 60 million vaccines by the end of 2022. The announcement […]
GENEVA – The COVID-19 pandemic had a devastating impact on the fight against HIV, TB and malaria in 2020, according to a new report released by the Global Fund today. The Results Report shows that while some progress was made, key programmatic results have declined for the first time in the history of the Global Fund. “To mark […]
Unitaid has invested more than US$ 45 million into hepatitis C since 2015, driving the development of better and more affordable tools and demonstrating that it is possible to reach – and cure – people in resource-limited settings. “We set out to improve hepatitis C care through a complementary set of investments. Over the past […]
Unitaid and the Clinton Health Access Initiative, Inc. (CHAI) announce pricing agreement with pharmaceutical company Hetero Labs LTD to make available generic version of best-in-class second-line therapy for people living with HIV Geneva, 26 July 2021 – Unitaid and CHAI today announced a groundbreaking pricing agreement with pharmaceutical company Hetero Labs LTD to make darunavir boosted […]
New mechanism builds on Gavi COVAX Advance Market Commitment (AMC) cost-sharing arrangement Washington DC / Geneva, 26 July 2021 – COVAX and the World Bank will accelerate COVID-19 vaccine supply for developing countries through a new financing mechanism that builds on Gavi’s newly designed AMC cost-sharing arrangement. This allows AMC countries to purchase doses beyond the […]
Technology transfer agreements signed to enable expanded production of high-quality antigen rapid tests in Africa and Latin America Agreements signed with DCN Dx to transfer know-how to WAMA Diagnóstica (Brazil), and Bionote and Mologic to transfer know-how to DIATROPIX of the Institut Pasteur de Dakar (Senegal) Separate partnership between Viatris (South Africa) and Guangzhou Wondfo Biotech […]
GENEVA – The Global Fund to Fight AIDS, Tuberculosis and Malaria praised the decision by the Swiss Federal Council to make available CHF300 million to the Access to COVID-19 Tools (ACT) Accelerator – a ground-breaking global collaboration of leading public health agencies to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines, […]
The Partnership for Vivax Elimination (PAVE) will support endemic countries in achieving their Plasmodium vivax (P. vivax) malaria elimination goals. PAVE will advance the development of quality-assured, child-friendly treatments for relapse prevention, and generate and consolidate evidence to support malaria-endemic countries in developing and implementing new strategies to eliminate P. vivax malaria. Geneva/Seattle, 14 July 2021 – The new Partnership […]
The signed advance purchase agreements will make doses available to COVAX starting from July to help address immediate and critical gaps in supply Addition of the Sinopharm and Sinovac vaccines, which have already been granted WHO Emergency Use Listing (EUL), further diversifies the Gavi-managed COVAX Facility portfolio, which now includes 11 vaccines and vaccine candidates […]
Geneva, 7 July 2021 – Unitaid welcomes new recommendations released by the World Health Organisation for the clinical care package for patients with severe or critical COVID-19, adding two medicines (tocilizumab and sarilumab). Having more treatment options is clearly of huge benefit, especially given the current concerning epidemiological situation around the world. Equitable access arrangements for medicines to treat […]
Geneva/New York/Oslo, 1 July 2021 – COVAX was built on the principle of equitable access to COVID-19 vaccines to protect the health of people all across the globe. That means protecting their lives and livelihoods, including their ability to travel and conduct trade. As travel and other possibilities begin to open up in some parts of […]
